Analysis of the receptor activator of NF-κB Ligand/Osteoprotegerin (RANKL/OPG) ratio as potential biomarker for infection-related bone destruction in pyogenic vertebral osteomyelitis
Objectives: Circulating soluble Receptor Activator of NF- κ B Ligand (sRANKL) and soluble Osteoprotegerin (sOPG) serum levels have been suggested as biomarkers for different aspects of bone diseases [ref:1], [ref:2]. We aimed to characterize the relation between the local mRNA [for full text, please go to the a.m. URL]
Institutions
- University Hospital Regensburg (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-10-21
- DOI
- https://doi.org/10.3205/24dkou115
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00